Skip to text Skip to main menu

(주)셀퓨릭스

Step into the future with CellPurics.

We are tirelessly innovating and advancing the health of both humans and pets.

Flexible testing process focusing on new drug substances and systematic non-clinical experimental research grounded in scientific principles.

With our extensive experience and expertise in getting approvals for various drugs, we promise to deliver the best results to meet your needs.

We strive to enhance the health and happiness of pets through innovative research and development.

Our goal is to provide healthcare solutions for pets that match the standards of human healthcare,
fostering collaboration between doctors and veterinarians to establish a complementary system.

CELLPURICS

TECHNOLOGY

Technology

01 / 03

Mass Culture and Storage of Germline Stem Cells

We leverage our proprietary technology to produce and develop cell therapeutics for pet diseases.

View more

Technology

02 / 03

Real-time PCR-based Measurement of Anti-inflammatory Effects of Mesenchymal Stem Cells

We use the multiplex real-time PCR technology to quantitatively measure anti-inflammatory effects.

View more

Technology

03 / 03

Cutting-edge Pets Diagnosis Technology

We utilize the one and only veterinary diagnostic
protocol in Korea to test for a range of pet diseases.

View more

Technology

01 / 03

Mass Culture and Storage of Germline Stem Cells

We leverage our proprietary technology to produce and develop cell therapeutics for pet diseases.

View more

Technology

02 / 03

Real-time PCR-based Measurement of Anti-inflammatory Effects of Mesenchymal Stem Cells

We use the multiplex real-time PCR technology to quantitatively measure anti-inflammatory effects.

View more

Technology

03 / 03

Cutting-edge Pets Diagnosis Technology

We utilize the one and only veterinary diagnostic
protocol in Korea to test for a range of pet diseases.

View more

CELLPURICS

NEWS

View more

케이메디허브-셀퓨릭스, 반려동물용 세포치료제 공동연...

케이메디허브(대구경북첨단의료산업진흥재단, 이사장 양진영) 전임상센터는 3일 셀퓨릭스와 반려동물용 세포치료제 및 의약품 개발 협력을 위...

2024-08-06

셀퓨릭스, 바이오톡스텍과 '인간화 마우스 활용 비임상 ...

셀퓨릭스(대표이사 신지웅)는 바이오톡스텍과 지난달 4월 23일 인간화 마우스를 활용한 비임상시험 사업영역 구축 및 교류를 위한 MOU를 체결...

2024-08-06

뉴스/기사 게시판입니다.

2024-07-30